Ranganna Kasturi, Mathew Omana P, Yatsu Frank M, Yousefipour Zivar, Hayes Barbara E, Milton Shirlette G
Department of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.
FEBS J. 2007 Nov;274(22):5962-78. doi: 10.1111/j.1742-4658.2007.06119.x. Epub 2007 Oct 24.
Vascular smooth muscle cell (VSMC) proliferation is an important etiological factor in vascular proliferative diseases such as primary atherosclerosis, hypertension, arterial and in-stent restenosis, and transplant vasculopathy. Our studies established that butyrate, a bacterial fermentation product of dietary fiber and a chromatin modulator, is a potent inhibitor of VSMC proliferation. The cardiovascular health benefits of a high-fiber diet, the principle source of butyrate in the body, have been known for a long time, however, very little is known about the antiatherogenic potential of butyrate. Because oxidative stress plays an important role in the pathogenesis of atherosclerosis, we examined involvement of the glutathione/glutathione S-transferase (GST) antioxidant system in butyrate's inhibition of VSMC proliferation. Treatment of proliferating VSMCs with butyrate leads to the induction of several GSTs. Interestingly, our study also demonstrated the nuclear localization of GST-P1 (GST-7-7), which is considered to be a cytosolic protein; this was demonstrated using immunostaining and was corroborated by western blotting. Also, the butyrate-induced antiproliferative action, and the induction of GST-P1 and its nuclear localization are downregulated when butyrate is withdrawn. Furthermore, assessment of intracellular glutathione levels reveals their augmentation by butyrate. Conversely, butyrate treatment reduces the levels of reactive oxygen species in VSMCs. Collectively, the butyrate-treatment-related increase in glutathione content, the reduction in reactive oxygen species, the upregulation of GST and the nuclear localization of GST-P1 in growth-arrested VSMCs imply that butyrate's antiproliferative action involves modulation of the cellular redox state. Thus, induction of the glutathione/GST antioxidant system appears to have other regulatory role(s) besides detoxification and regulation of the cellular redox state, for example, cell-cycle control and cell proliferation, which are both critical to atherogenesis.
血管平滑肌细胞(VSMC)增殖是原发性动脉粥样硬化、高血压、动脉及支架内再狭窄和移植血管病变等血管增殖性疾病的重要病因。我们的研究表明,丁酸盐作为膳食纤维的细菌发酵产物和染色质调节剂,是VSMC增殖的有效抑制剂。高纤维饮食是体内丁酸盐的主要来源,其对心血管健康有益,这一点早已为人所知,然而,关于丁酸盐的抗动脉粥样硬化潜力却知之甚少。由于氧化应激在动脉粥样硬化的发病机制中起重要作用,我们研究了谷胱甘肽/谷胱甘肽S-转移酶(GST)抗氧化系统在丁酸盐抑制VSMC增殖中的作用。用丁酸盐处理增殖的VSMC会诱导多种GST的产生。有趣的是,我们的研究还证明了GST-P1(GST-7-7)的核定位,而GST-P1通常被认为是一种胞质蛋白;这通过免疫染色得到证实,并经蛋白质印迹法确证。此外,当撤去丁酸盐时,丁酸盐诱导的抗增殖作用以及GST-P1的诱导及其核定位都会下调。此外,对细胞内谷胱甘肽水平的评估显示丁酸盐可使其增加。相反,丁酸盐处理可降低VSMC中活性氧的水平。总体而言,丁酸盐处理导致生长停滞的VSMC中谷胱甘肽含量增加、活性氧减少、GST上调以及GST-P1核定位,这表明丁酸盐的抗增殖作用涉及细胞氧化还原状态的调节。因此,谷胱甘肽/GST抗氧化系统的诱导除了在解毒和调节细胞氧化还原状态方面发挥作用外,似乎还具有其他调节作用,例如细胞周期控制和细胞增殖,而这两者对动脉粥样硬化的发生都至关重要。